STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation
Condition(s):Coronary Artery DiseaseLast Updated:May 22, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Coronary Artery DiseaseLast Updated:May 22, 2018Terminated
Condition(s):Multi Vessel Coronary Artery DiseaseLast Updated:December 22, 2021Unknown status
Condition(s):Cardiovascular Diseases; Heart Diseases; Coronary Disease; Diabetes Mellitus; Atherosclerosis; Cerebral Arteriosclerosis; HypertensionLast Updated:September 15, 2017Completed
Condition(s):Drug Interaction Potentiation; Myocardial InfarctionLast Updated:March 27, 2017Completed
Condition(s):Coronary Artery DiseaseLast Updated:June 10, 2015Completed
Condition(s):Diabetes Mellitus; Coronary DiseaseLast Updated:June 17, 2013Unknown status
Condition(s):Coronary Artery DiseaseLast Updated:November 21, 2014Unknown status
Condition(s):Coronary Artery Bypass Graft Triple Vessel; Blood Coagulation DisordersLast Updated:January 11, 2013Completed
Condition(s):Pre-Gestational DiabetesLast Updated:August 27, 2018Unknown status
Condition(s):Gastric Ulcer Induced by Anti-platelet Agent; Duodenal Ulcer Induced by Anti-platelet AgentLast Updated:February 27, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.